FIDELIO-ITN

@FIDELIO_ITN

EU-funded training network for research into bone Fragility In Diabetes in Europe: towards a personaLised medIcine apprOach (no.860898). Tweeting our own views.

Vrijeme pridruživanja: rujan 2019.

Tweetovi

Blokirali ste korisnika/cu @FIDELIO_ITN

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @FIDELIO_ITN

  1. 3. velj

    New population cohort study on composition and functional differences between microbiota of children and adults from our

    Poništi
  2. 30. sij

    Introducing our Austrian industry partner TamiRNA GmbH innovators in diagnostics, whose ESR13 will investigate mechanisms of recently identified biomarker miR-203a in T2D bone disease.

    Poništi
  3. proslijedio/la je Tweet
    24. sij

    Interested in how we can use time-lapsed quantification of a mouse defect healing model to investigate the association between mineralised tissue formation and the mechanical local in vivo environment. Check out our newest article .

    Poništi
  4. proslijedio/la je Tweet
    24. sij
    Poništi
  5. 23. sij

    Dr Carolina Medina-Gomez will supervise ESR11 investigating the potentially beneficial effects of diabetes treatment on bone outcomes and risk using data from the Rotterdam study

    Prikaži ovu nit
    Poništi
  6. 23. sij

    Dr Ling Oei will supervise ESR10 working on genetics and biologic pathways underlying risk in type 2 diabetes, mining data from genome-wide association studies

    Prikaži ovu nit
    Poništi
  7. 23. sij

    Introducing our Netherlands partners Fernando Rivadeniera , Ling Oei and Carolina Medina-Gomez from the Genetic Laboratory

    Prikaži ovu nit
    Poništi
  8. proslijedio/la je Tweet
    22. sij

    metabolism is regulated by the system. Understanding how circadian disruptions adversely impact glycaemic control may aid in prevention and treatment of type 2 diabetes mellitus

    Poništi
  9. proslijedio/la je Tweet
    21. sij

    Brittle bones in diabetes. Broze botten van diabetespatiënten

    Poništi
  10. 20. sij
    Poništi
  11. 16. sij

    Introducing our UK partner Prof Richard Eastell whose ESR9 will study the role of in diabetic bone disease and collaborate with our industry partner TamiRNA

    Poništi
  12. 15. sij
    Poništi
  13. proslijedio/la je Tweet
    14. sij

    Please note: abstract & clinical case submission deadline has been extended to 15 January 2020

    Poništi
  14. proslijedio/la je Tweet
    13. sij
    Poništi
  15. proslijedio/la je Tweet
    12. sij

    Interested in helping us to run a world class laboratory . Consider applying for an open position as a Lab Manager :

    Poništi
  16. proslijedio/la je Tweet
    9. sij

    Il di tipo 2 è una vera e propria . L’insorgere sempre più diffuso della patologia dipende da uno stile di vita errato, dall'alimentazione ricca di grassi e dalla scarsa attività fisica. Ce ne parla Paolo Pozzilli. 👉🏻

    Ovo je potencijalno osjetljiv multimedijski sadržaj. Saznajte više
    Poništi
  17. 9. sij

    Introducing also at Prof Andrea Burden whose ESR14 will investigate if specific subgroups of patients or medications are associated with a higher risk of

    Poništi
  18. proslijedio/la je Tweet
    3. sij

    Join our second seminar on translational, cross-disciplinary and cross-sectorial diabetes research in the Region of Southern Denmark to network and to create fruitful collaborations with fellow researchers

    Poništi
  19. 2. sij

    Introducing our partner Prof Ralph Muller Laboratory of Bone Biomechanics whose ESR8 will study of bone remodelling in type 2 using patient data

    Poništi
  20. proslijedio/la je Tweet
    16. pro 2019.

    New Guidelines for Data Reporting and Statistical Analysis: Helping Authors with Transparency and Rigor in Research

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·